Sosa Liprandi María Inés, Elfman Melisa, Zaidel Ezequiel José, Viniegra Matías, Sosa Liprandi Álvaro
Cardiology Department, Sanatorio Güemes, Buenos Aires, Argentina.
Cardiology Department, Sanatorio Güemes, Buenos Aires, Argentina.
Curr Probl Cardiol. 2023 Jun;48(6):101624. doi: 10.1016/j.cpcardiol.2023.101624. Epub 2023 Jan 29.
The aim of this study was to describe the safety, effectiveness, and usability of a mobile-app based follow up platform after a heart failure (HF) hospitalization. It was a pilot, prospective implementation study. 55 consecutive patients were included. Over 12 months, a significant increase in the use of renin angiotensin system inhibitors was observed (91% vs 76%, P < 0.04). Medication adherence, assessed by daily patient validation in the app was 96%. No relevant changes were found in biochemical evaluations. The parameters of app usability showed a high value. At 12 months follow-up one patient was hospitalized for HF (1/55 [1,8%]), there was no cardiovascular death, and 5 patients had non-cardiovascular deaths (5/55 [9.1%]). In patients recently discharged from HF hospitalization, the implementation of non-invasive telemedicine follow-up was feasible, safe and an effective strategy to increase the adherence to medical therapy. A high degree of clinical stability and a low rate of events were observed over 1-year.
本研究的目的是描述心力衰竭（HF）住院后基于移动应用程序的随访平台的安全性、有效性和可用性。这是一项试点前瞻性实施研究。纳入了55例连续患者。在12个月期间，观察到肾素血管紧张素系统抑制剂的使用显著增加（91%对76%，P<0.04）。通过应用程序中每日患者验证评估的药物依从性为96%。生化评估未发现相关变化。应用程序可用性参数显示出较高值。在12个月随访时，1例患者因HF住院（1/55[1.8%]），无心血管死亡，5例患者有非心血管死亡（5/55[9.1%]）。在近期因HF住院出院的患者中，实施非侵入性远程医疗随访是可行、安全且有效的增加药物治疗依从性的策略。在1年期间观察到高度的临床稳定性和低事件发生率。
